Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$93,578,336
+$22,431,369 QoQ
Shares Held
78,019
+0.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#394
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $425,890,657 across 14 Drug Manufacturers - General names. LLY ranks #2 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
412,665 | $104,804,529 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
78,019 | $93,578,336 | |
| 3 | MRK |
Merck & Co., Inc.
|
563,132 | $72,362,462 | |
| 4 | ABBV |
AbbVie Inc.
|
209,332 | $52,676,303 | |
| 5 | AMGN |
Amgen Inc
|
87,050 | $31,522,545 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
439,307 | $25,312,868 | |
| 7 | PFE |
Pfizer Inc
|
879,706 | $21,183,319 | |
| 8 | AZN |
Astrazeneca PLC
|
72,990 | $13,840,363 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,578,336 | 78,019 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $71,146,967 | 77,353 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $84,856,739 | 78,960 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $61,697,706 | 80,862 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $61,891,562 | 79,396 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $62,757,596 | 75,986 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $57,219,868 | 74,119 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $65,229,103 | 73,627 | Shares | Defined | 2024-11-26 | |
| 2024-06-30 | $69,661,746 | 76,942 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $60,025,058 | 77,157 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $45,535,378 | 78,116 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $43,909,302 | 81,748 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $38,535,616 | 82,169 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $30,150,901 | 87,796 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $33,629,840 | 91,925 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,222,876 | 93,468 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,632,725 | 75,973 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $22,181,646 | 77,458 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,921,094 | 79,361 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $16,638,141 | 72,011 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,988,150 | 74,016 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,035,972 | 75,131 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $11,939,013 | 70,712 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,798,479 | 66,197 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $12,119,602 | 73,819 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,542,580 | 75,999 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||